CC BY-NC-ND 4.0 · Arquivos Brasileiros de Neurocirurgia: Brazilian Neurosurgery 2022; 41(02): e167-e173
DOI: 10.1055/s-0041-1734013
Review Article

Oncotic (Myxomatous) Aneurysms: A Review of Management

Aneurismas oncóticos (mixomatosos): Revisão das opções de tratamento
1   Neurosurgery Service, Hospital Santa Julia, Manaus, AM, Brazil
2   Neuroradiology Service, Fundação Hospital do Coração Francisca Mendes, Manaus, AM, Brazil
,
1   Neurosurgery Service, Hospital Santa Julia, Manaus, AM, Brazil
2   Neuroradiology Service, Fundação Hospital do Coração Francisca Mendes, Manaus, AM, Brazil
,
3   Faculty of Medicine, Universidade de São Paulo, São Paulo, SP, Brazil
,
4   Sensumed Oncologia, Manaus, AM, Brazil
,
5   Clínica Prodimagem, Manaus, AM, Brazil
› Author Affiliations

Abstract

Atrial myxomas are the most common primary cardiac tumors and may manifest with neurological symptoms in ∼ 30% of cases. Cerebral ischemia, aneurysmal formation, and extravascular metastases are mechanisms that lead to these neurological manifestations. Perilesional changes on computed tomography (CT) and magnetic resonance imaging (MRI) may help in the diagnosis of myxomatous aneurysms, which are usually located in the distal middle cerebral artery (MCA) and in the posterior cerebral artery (PCA) circulation territories. Careful resection of the cardiac lesion is essential for preventing embolism. However, treatment of myxomatous aneurysms is controversial due to the limited understanding of the natural history of this condition. Treatment may include clinical observation in asymptomatic patients, surgical resection, endovascular approaches, adjuvant chemotherapy, and low-dose radiation therapy. We present one case of a female patient with myxomatous aneurysm secondary to an atrial myxoma who presented with neurological symptoms and another case of a female patient who developed neurological symptoms after initial surgical treatment of the primary lesion. Lesion growth rate, topography, morphology, and the patient's clinical condition must be considered when choosing a therapeutical method. Further clinical studies are needed to achieve a better understanding and treatment of this disease.

Resumo

Mixomas atriais são os tumores primários cardíacos mais comuns. Podem levar a manifestações neurológicas em cerca de 30% dos pacientes devido a: isquemia cerebral, formação de aneurismas e metástases extravasculares. Alterações perilesionais encontradas tanto nas de tomografia (TC) ou ressonância magnética (RM) podem ajudar no diagnóstico de aneurismas mixomatosos, que geralmente envolvem ramos distais das artérias cerebral média e posterior. Ressecção cirôrgica cuidadosa da lesão cardíaca é essencial para prevenção de eventos embólicos. Entretanto, por sua história natural mal conhecida devida à raridade da condição, o tratamento dos aneurismas mixomatosos é controverso, incluindo conduta conservadora em pacientes assintomáticos, abordagem cirôrgica, endovascular, quimioterapia adjuvante e radioterapia em baixas doses. Discutiremos dois casos clínicos de pacientes femininas com aneurismas mixomatosos, tendo o primeiro caso o acometimento neurológico como manifestação inicial e o segundo com sintomas posteriores ao tratamento cirôrgico do tumor primário. Determinação da melhor escolha do tratamento deve levar em consideração taxa de crescimento da lesão, sua topografia, morfologia e clínica do paciente. Mais estudos clínicos são necessários para melhor compreensão e definição de conduta desses pacientes.



Publication History

Received: 18 April 2021

Accepted: 30 July 2021

Article published online:
13 January 2022

© 2022. Sociedade Brasileira de Neurocirurgia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. (https://creativecommons.org/licenses/by-nc-nd/4.0/)

Thieme Revinter Publicações Ltda.
Rua do Matoso 170, Rio de Janeiro, RJ, CEP 20270-135, Brazil

 
  • References

  • 1 Sandok BA, von Estorff I, Giuliani ER. Subsequent neurological events in patients with atrial myxoma. Ann Neurol 1980; 8 (03) 305-307
  • 2 Liao WH, Ramkalawan D, Liu JL. et al. The imaging features of neurologic complications of left atrial myxomas. Eur J Radiol 2015; 84 (05) 933-939
  • 3 Wen XY, Chen YM, Yu LL. et al. Neurological manifestations of atrial myxoma: A retrospective analysis. Oncol Lett 2018; 16 (04) 4635-4639
  • 4 Zhang S, Zhang Q, Yu H. et al. Neuroimaging characteristics and long-term prognosis of myxoma-related intracranial diseases. Neuroradiology 2020; 62 (03) 307-317
  • 5 Larsson S, Lepore V, Kennergren C. Atrial myxomas: results of 25 years' experience and review of the literature. Surgery 1989; 105 (06) 695-698
  • 6 Swartz MF, Lutz CJ, Chandan VS, Landas S, Fink GW. Atrial myxomas: pathologic types, tumor location, and presenting symptoms. J Card Surg 2006; 21 (04) 435-440
  • 7 Pinede L, Duhaut P, Loire R. Clinical presentation of left atrial cardiac myxoma. A series of 112 consecutive cases. Medicine (Baltimore) 2001; 80 (03) 159-172
  • 8 Yuan SM, Lin HZ. Interleukin-6 in Patients with Cardiac Myxoma. J Coll Physicians Surg Pak 2020; 30 (08) 849-852
  • 9 Xu Q, Zhang X, Wu P, Wang M, Zhou Y, Feng Y. Multiple intracranial aneurysms followed left atrial myxoma: case report and literature review. J Thorac Dis 2013; 5 (06) E227-E231
  • 10 Yuan SM, Lin HZ. Predictors of Normalization of Circulating Interleukin-6 after Cardiac Myxoma Resection. Braz J Cardiovasc Surg 2019; 34 (01) 22-27
  • 11 Ha JW, Kang WC, Chung N. et al. Echocardiographic and morphologic characteristics of left atrial myxoma and their relation to systemic embolism. Am J Cardiol 1999; 83 (11) 1579-1582 , A8
  • 12 Kalçık M, Bayam E, Güner A. et al. Evaluation of the potential predictors of embolism in patients with left atrial myxoma. Echocardiography 2019; 36 (05) 837-843
  • 13 Dong A, Lu J, Zuo C. Multiple Peripheral Pulmonary Artery Aneurysms in Association With a Right Atrial Myxoma. Circulation 2016; 133 (04) 444-446
  • 14 Lee VH, Connolly HM, Brown Jr RD. Central nervous system manifestations of cardiac myxoma. Arch Neurol 2007; 64 (08) 1115-1120
  • 15 Rajeshwari M, Subramanian P, Suri V. et al. Metastatic lesions of atrial myxoma. A pathologist can clinch them all. Neuropathology 2020; 40 (03) 295-301
  • 16 Eddleman CS, Gottardi-Littell NR, Bendok BR, Batjer HH, Bernstein RA. Rupture of cerebral myxomatous aneurysm months after resection of the primary cardiac tumor. Neurocrit Care 2010; 13 (02) 252-255
  • 17 Sedat J, Chau Y, Dunac A, Gomez N, Suissa L, Mahagne MH. Multiple cerebral aneurysms caused by cardiac myxoma. A case report and present state of knowledge. Interv Neuroradiol 2007; 13 (02) 179-184
  • 18 Hwang BJ, Connelly MM, Lev MH. Distinctive MR imaging appearance of hemorrhagic cerebral aneurysms associated with atrial myxoma. AJR Am J Roentgenol 2001; 177 (04) 925-927
  • 19 Zheng J, Zhang J. Neoplastic cerebral aneurysm from metastatic tumor: a systematic review of clinical and treatment characteristics. Clin Neurol Neurosurg 2015; 128: 107-111
  • 20 Zheng J, Li S, Cao Y, Wang S, Wang R, Zhao J. Multiple cerebral myxomatous aneurysms: what is the optimal treatment?. J Stroke Cerebrovasc Dis 2015; 24 (01) 232-238
  • 21 Bernet F, Stulz PM, Carrel TP. Long-term remission after resection, chemotherapy, and irradiation of a metastatic myxoma. Ann Thorac Surg 1998; 66 (05) 1791-1792
  • 22 Kesav P, John S, Joshi P, Gaba WH, Hussain SI. Cardiac Myxoma Embolization Causing Ischemic Stroke and Multiple Partially Thrombosed Cerebral Aneurysms. Stroke 2021; 52 (01) e10-e14
  • 23 Josephson SA, Johnston SC. Multiple stable fusiform intracranial aneurysms following atrial myxoma. Neurology 2005; 64 (03) 526
  • 24 Khatibi K, Ponce Mejia LL, Kaneko N. et al. Targeted Radiation Therapy Can Treat Myxomatous Cerebral Aneurysms. World Neurosurg 2020; 143: 332-335
  • 25 Peres CMA, Figueiredo EG, Yamaki VN. The Natural History of Brain Arteriovenous Malformations. Braz Neurosurg 2017; 36 (03) 153-159
  • 26 Peres CMA, Souza EC, Teixeira MJ, Figueiredo EG, Caldas JGMP. Impact of Associated Nidal Lesions in Outcome of Brain Arteriovenous Malformations After Radiosurgery with or without Embolization. World Neurosurg 2017; 105: 643-650
  • 27 Branscheidt M, Frontzek K, Bozinov O. et al. Etoposide/carboplatin chemotherapy for the treatment of metastatic myxomatous cerebral aneurysms. J Neurol 2014; 261 (04) 828-830
  • 28 Penn DL, Lanpher AB, Klein JM. et al. Multimodal treatment approach in a patient with multiple intracranial myxomatous aneurysms. J Neurosurg Pediatr 2018; 21 (03) 315-321
  • 29 Saffie P, Riquelme F, Mura J. et al. Multiple myxomatous aneurysms with bypass and clipping in a 37-year-old man. J Stroke Cerebrovasc Dis 2015; 24 (03) e69-e71
  • 30 Li Z, Xu X, Hu L, Sun H, Yue Y. Intracranial Aneurysms After Intravenous Thrombolysis in Patient with Atrial Myxoma: A Case Study. J Stroke Cerebrovasc Dis 2020; 29 (06) 104796